These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23663044)

  • 1. The authors' reply: oestradiol concentrations are not elevated in obesity-associated hypogonadotrophic hypogonadism.
    Aftab SS; Kumar S; Barber TM
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):465. PubMed ID: 23663044
    [No Abstract]   [Full Text] [Related]  

  • 2. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes.
    Bhatia V; Chaudhuri A; Tomar R; Dhindsa S; Ghanim H; Dandona P
    Diabetes Care; 2006 Oct; 29(10):2289-94. PubMed ID: 17003308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt--a major factor in the genesis of morbid obesity.
    Cohen PG
    Med Hypotheses; 1999 Jan; 52(1):49-51. PubMed ID: 10342671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypogonadism in a male-to-female transsexual with super obesity.
    Ayanian S; Irwig MS
    Andrologia; 2013 Aug; 45(4):285-8. PubMed ID: 22783836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestradiol concentrations are not elevated in obesity-associated hypogonadotrophic hypogonadism.
    Dhindsa S; Batra M; Kuhadiya N; Dandona P
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):464. PubMed ID: 23647503
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alstrom syndrome.
    Rajan SK; Ameen KH; Hariharan C; Natarajhan VS
    J Assoc Physicians India; 2002 Feb; 50():278. PubMed ID: 12038666
    [No Abstract]   [Full Text] [Related]  

  • 8. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity in men: the hypogonadal-estrogen receptor relationship and its effect on glucose homeostasis.
    Cohen PG
    Med Hypotheses; 2008; 70(2):358-60. PubMed ID: 17825496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.
    Corona G; Mannucci E; Forti G; Maggi M
    Int J Androl; 2009 Dec; 32(6):587-98. PubMed ID: 19226407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes mellitus and testosterone: a meta-analysis study.
    Corona G; Monami M; Rastrelli G; Aversa A; Sforza A; Lenzi A; Forti G; Mannucci E; Maggi M
    Int J Androl; 2011 Dec; 34(6 Pt 1):528-40. PubMed ID: 20969599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
    Holbrook JM; Cohen PG
    South Med J; 2003 Jun; 96(6):544-7. PubMed ID: 12938779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
    de Boer H; Verschoor L; Ruinemans-Koerts J; Jansen M
    Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism.
    Saboor Aftab SA; Kumar S; Barber TM
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):330-7. PubMed ID: 23121123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male hypogonadism. Part I: Epidemiology of hypogonadism.
    Seftel AD
    Int J Impot Res; 2006; 18(2):115-20. PubMed ID: 16193071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadism and diabetes.
    Betancourt-Albrecht M; Cunningham GR
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural, metabolic and endocrine analysis of the diabetes (db/db) hypogonadal syndrome: relationship to hypophyseal hypercytolipidemia.
    Garris DR; Garris BL; Novikova L; Lau YS
    Cell Tissue Res; 2005 Mar; 319(3):501-12. PubMed ID: 15672265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypogonadotrophic hypogonadism in type 2 diabetes.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
    Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
    Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P
    Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.